Drug name - Qulipta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9499545 ABBVIE INC Piperidinone carboxamide azaindane CGRP receptor antagonists
Nov, 2031

(9 years from now)

US8754096 ABBVIE INC Piperidinone carboxamide azaindane CGRP receptor antagonists
Jul, 2032

(9 years from now)

US9850246 ABBVIE INC Process for making CGRP receptor antagonists
Mar, 2033

(10 years from now)

CN103328478A ABBVIE INC Piperidones Carboxamide Indane Cgrp Receptor Antagonist
Nov, 2031

(9 years from now)

CN103328478B ABBVIE INC Piperidone Carboxamide Nitrogen Mixed Indene Into Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

IN201303390P4 ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

IN289826B ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2821407B1 ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2638042A1 ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2821407A1 ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2638042B1 ABBVIE INC Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2849568B1 ABBVIE INC Process For Making Cgrp Receptor Antagonists
Mar, 2033

(10 years from now)

EP2849568A4 ABBVIE INC Process For Making Cgrp Receptor Antagonists
Mar, 2033

(10 years from now)

EP2849568A1 ABBVIE INC Process For Making Cgrp Receptor Antagonists
Mar, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10117836 ABBVIE INC Tablet formulation for CGRP active compounds Jan, 2035

(12 years from now)

Drugs and Companies using ATOGEPANT ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
10MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
60MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.